Tesla

Amazon

Morgan Stanley

Charles Schwab

Goldman Sachs

QUALCOMM

Wynn Resorts

DraftKings

BlackRock

Hyatt Hotels

The Nightview Fund

NightstaRx Ltd. is a U.K. startup company. Gene therapy is the use of a gene to treat disease. The approach could enable treatments for a several rare conditions caused by mutations in a single gene.

NITE actively manages a narrow portfolio of US equity securities. The fund aims for long-term capital appreciation while attempting to beat the S&P 500 over five years.

We recently transitioned the Long Only fund to an Exchange Trade Fund (ETF). As of June 21, 2024, The Nightview Fund (“NITE”) ETF trades on the New York Stock Exchange under the ticker NITE. In our Q2 2024 letter, we offer a top conviction idea: Amazon.

The Nightview Fund Q2 2024 Investor Letter

On Monday, Nightview Capital made its debut on the ETF market with the launch of The Nightview Fund (NITE). The fund is actively managed and carries a net expense ratio of 1.25%.

News for The Nightview Fund ETF (NITE)